TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
21 hedge funds and large institutions have $371K invested in Titan Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
2
Closed
5
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
-$41K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$107K |
| 2 |
VF
Virtu Financial
New York
|
+$94.3K |
| 3 |
Renaissance Technologies
New York
|
+$62K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.78K |
